Advertisements
This page lists 635 references in the Main Healthy Skepticism Library relevant to Advertisements.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6927
Cassels A.
Cholesterol TV ads clog reality
Common Ground Magazine 2006 Nov 1
HSL6950
Big pharma calling journals' shots?
New Scientist magazine 2006 Oct 15
HSL6829
Connor SM.
Food-related advertising on preschool television: building brand recognition in young viewers.
Pediatrics 2006 Oct 01;118(4):1478-85
http://pediatrics.aappublications.org/
HSL6831
Brown JD.
Media literacy has potential to improve adolescents' health.
J Adolesc Health 2006 Oct 01;39(4):459-60
http://linkinghub.elsevier.com/retrieve/pii/S1054-139X(06)00277-1
HSL6739
Pollack A.
The wide, wild world of genetic testing.
NY Times (Print) 2006 Sep 12;NYT4
HSL6686
Sleeping pills: are they worth the risk?
Consum Rep 2006 Sep 01;71(9):48-9
HSL6797
Fox MD.
Sleeping with the enemy: Garfield and the National Heart, Lung, and Blood Institute.
Pediatrics 2006 Sep 01;118(3):1257-8
HSL6834
Weber K, Story M, Harnack L.
Internet food marketing strategies aimed at children and adolescents: a content analysis of food and beverage brand web sites.
J Am Diet Assoc 2006 Sep 01;106(9):1463-6
http://linkinghub.elsevier.com/retrieve/pii/S0002-8223(06)01391-5
HSL6978
Kahn J.
Race, pharmacogenomics, and marketing: putting BiDil in context.
Am J Bioeth 2006 Sep-Oct 01;6(5):W1-5
Link to source with long URL
HSL6796
Twery MJ.
The cartoon character garfield and the 'sleep well. Do well. Star sleeper' campaign.
Pediatrics 2006 Sep;118(3):1259
HSL6516
Dyer O.
GSK breached marketing code.
BMJ 2006 Aug 19;333(7564):368
http://bmj.bmjjournals.com/cgi/content/short/333/7564/368-a?etoc%3e
HSL6535
Mintzberg H.
Patent nonsense: evidence tells of an industry out of social control.
CMAJ 2006 Aug 15;175(4):374
http://www.cmaj.ca/cgi/content/full/175/4/374
HSL6687
Salinsky E.
Effects of food marketing to kids: I'm lovin' it?
Issue Brief Natl Health Policy Forum 2006 Aug 15(814):1-16
HSL6693
Nestle M.
Food industry and health: mostly promises, little action.
Lancet 2006 Aug 12;368(9535):564-5
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)69177-0
HSL6691
Kormeset PO.
[Written drug advertisements].
Tidsskr Nor Laegeforen 2006 Aug 10;126(15):1946
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1407848
HSL6541
The business of HIV/AIDS.
Lancet 2006 Aug 5;368(9534):423
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)69124-1
HSL6649
Heinig MJ.
The international code of marketing of breastmilk substitutes: the challenge is choice.
J Hum Lact 2006 Aug 01;22(3):265-6
http://jhl.sagepub.com/cgi/reprint/22/3/265
HSL6706
Baxter P.
Medicine and the pharmaceutical industry.
Dev Med Child Neurol 2006 Aug 01;48(8):627
Link to source with long URL
HSL6150
Funding of patients' groups.
Lancet 2006 Jul 1;368(9529):2
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68941-1
HSL6397
Wilksch SM, Tiggemann M, Wade TD.
Impact of interactive school-based media literacy lessons for reducing internalization of media ideals in young adolescent girls and boys.
Int J Eat Disord 2006 Jul 01;39(5):385-93
Link to source with long URL
HSL6619
ACOG Committee on Ethics.
ACOG Committee Opinion No. 341 Ethical ways for physicians to market a practice
Obstet Gynecol. 2006 Jul 01;108(1):239-42
http://www.greenjournal.org/cgi/reprint/108/1/239
HSL6624
Folta SC, Goldberg JP, Economos C, Bell R, Meltzer R.
Food advertising targeted at school-age children: a content analysis.
J Nutr Educ Behav 2006 Jul-Aug 01;38(4):244-8
http://linkinghub.elsevier.com/retrieve/pii/S1499-4046(06)00295-8
HSL6700
Timmermans AE.
[Misleading advertisement on Opatanol].
Ned Tijdschr Geneeskd 2006 Jul 1;150(26):1472
HSL6805
Kesselheim AS, Fischer MA, Avorn J.
The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Health Aff (Millwood) 2006 Jul-Aug 01;25(4):1095-102
http://content.healthaffairs.org/cgi/content/full/25/4/1095
HSL6882
Flewell MN.
Pharmaceutical sales reps: value beyond samples.
Adv Nurse Pract 2006 Jul 01;14(7):18
HSL6324
MacDonald N, Downie J.
Editorial policy: industry funding and editorial independence.
CMAJ 2006 Jun 20;174(13):1817,
http://www.cmaj.ca/cgi/content/full/174/13/1817
HSL5719
Godllee F.
What price integrity?
BMJ 2006;332 (17 June), 2006 Jun 17;332
http://bmj.bmjjournals.com/cgi/content/short/332/7555/0-f?etoc
HSL6214
Jarhult B.
[Pre-launching of drugs--the RLS example].
Lakartidningen 2006 Jun 14-27;103(24-25):1985
HSL6394
Smith R.
Conflicts of interest: how money clouds objectivity.
J R Soc Med 2006 Jun 01;99(6):292-7
http://www.jrsm.org/cgi/content/full/99/6/292http://
HSL6714
Ghisolfi J.
[Labelling, claims and infant or young child special foods].
Arch Pediatr 2006 Jun 01;13(6):560-1
Link to source with long URL
HSL6985
Stephens R, Hoskin P.
Clinical trials and modern advertising: the lung cancer trials flowchart.
Clin Oncol (R Coll Radiol) 2006 Jun 01;18(5):376-7
HSL5615
Cohen D.
Inconsistent position on SSRI ads.
CMAJ 2006 May 23;174(11):1597
http://www.cmaj.ca/cgi/content/full/174/11/1597-b
HSL5662
Schachter M, Wierzbicki AS.
Spinning stars: ASTEROID's impact on atherosclerosis.
Lancet 2006 May 20;367(9523):1655-6
Link to source with long URL
HSL5482
Brettingham M.
Department of Health ends contract with drugs bulletin.
BMJ 2006 May 13;332(7550):1109
http://bmj.bmjjournals.com/cgi/content/extract/332/7550/1109-a
HSL5483
Watson R.
Belgium to tighten drug advertising laws.
BMJ 2006 May 13;332(7550):1110
http://bmj.bmjjournals.com/cgi/content/full/332/7550/1110-a
HSL5579
Solhaug HR, Indermo H, Slordal L, Spigset O.
[Written drug advertisements--are they reliable?]
Tidsskr Nor Laegeforen 2006 May 11;126(10):1314-7
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1376195
HSL5624
Wilson N, Signal L, Nicholls S, Thomson G.
Hazardous and beneficial nutritional messages in 858 televised food advertisements during children's viewing hours.
N Z Med J 2006 May 5;119(1233):U1967
HSL6209
Dresser R.
Pharmaceutical company gifts: from voluntary standards to legal demands.
Hastings Cent Rep 2006 May-Jun 01;36(3):8-9
HSL6210
Shiwani MH.
Quest of prescribing practice in Pakistan.
J Pak Med Assoc 2006 May 01;56(5):249-50
HSL6225
Mahecha LA.
Rx-to-OTC switches: trends and factors underlying success.
Nat Rev Drug Discov 2006 May 01;5(5):380-5
http://www.nature.com/nrd/journal/v5/n5/abs/nrd2028.html
HSL6334
Lee ET, O'Riordan D, Swetter SM, Demierre MF, Brooks K, Geller AC.
Sun care advertising in popular U.S. magazines.
Am J Health Promot 2006 May-Jun 01;20(5):349-52
HSL6335
Burkitt JA, Saucier DM, Thomas NA, Ehresman C.
When advertising turns 'cheeky'!
Laterality 2006 May 01;11(3):277-86
Link to source with long URL
HSL6620
Kids are different.
Profiles Healthc Commun 2006 May-Jun 01;22(3):20-4,
HSL6621
GE Healthcare launches multiphase advertising effort.
Profiles Healthc Commun 2006 May-Jun 01;22(3):11-9,
HSL6622
Michigan health system launches integrated campaign using patient testimonials.
Profiles Healthc Commun 2006 May-Jun 01;22(3):1-9,
HSL6655
Bundesministerium fur Gesundheit.
[Regulation for control of advertising cosmetic operations set into effect].
Kinderkrankenschwester 2006 May 01;25(5):211
HSL6716
Cowden AL, Katz KA.
Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
Br J Dermatol 2006 May 01;154(5):950-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2006.07168.x
HSL6105
Grace M.
Ethical marketing.
Br Dent J 2006 Apr 22;200(8):418
http://www.nature.com/doifinder/10.1038/sj.bdj.4813532
HSL6546
Ivanitskaya L, O'Boyle I, Casey AM.
Health information literacy and competencies of information age students: results from the interactive online Research Readiness Self-Assessment (RRSA).
J Med Internet Res 2006 Apr 21;8(2):e6
http://www.jmir.org/2006/2/e6/
HSL6336
Carter OB.
The weighty issue of Australian television food advertising and childhood obesity.
Health Promot J Austr 2006 Apr 01;17(1):5-11
HSL6698
Aggett P.
Evidence based nutrition and health claims on foods: a renaissance?
Matern Child Nutr 2006 Apr 01;2(2):65-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1740-8709.2006.00056.x
HSL6719
Curry P, O'Brien M.
The male heart and the female mind: a study in the gendering of antidepressants and cardiovascular drugs in advertisements in Irish medical publication.
Soc Sci Med 2006 Apr 01;62(8):1970-7
Link to source with long URL
HSL5628
Christakis DA, Zimmerman FJ.
Media as a public health issue.
Arch Pediatr Adolesc Med 2006 Apr;160(4):445-6
http://archpedi.ama-assn.org/cgi/content/full/160/4/445
HSL5629
Chamberlain LJ, Wang Y, Robinson TN.
Does children's screen time predict requests for advertised products? Cross-sectional and prospective analyses.
Arch Pediatr Adolesc Med 2006 Apr;160(4):363-8
Link to source with long URL
HSL5348
Meek C.
SSRI ads questioned.
CMAJ 2006 Mar 14;174(6):754
Link to source with long URL
HSL5571
Cardarelli R, Licciardone JC, Taylor LG.
A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
BMC Fam Pract 2006 Mar 3;7(13)
http://www.biomedcentral.com/1471-2296/7/13
HSL5504
Drowning or thirsting: the extremes of availability of medical information.
PLoS Med 2006 Mar 01;3(3):e165
Link to source with long URL
HSL5505
Smith R.
The trouble with medical journals.
J R Soc Med 2006 Mar 01;99(3):115-9
http://www.jrsm.org/cgi/content/full/99/3/115
HSL5660
Engelman K.
Rx: professional integrity (prn).
J Clin Hypertens (Greenwich) 2006 Mar 01;8(3):232
Link to source with long URL
HSL6647
Felsenfeld AL.
How sweet it isn't.
J Calif Dent Assoc 2006 Mar 01;34(3):193-4
HSL6717
Carvalho MC, Accioly Junior H, Raffin FN.
[Social representations of generic drugs by consumers from Natal, Rio Grande do Norte, Brazil].
Cad Saude Publica 2006 Mar 01;22(3):653-61
Link to source with long URL
HSL5384
Atkinson M, Bevan R, Becker S, Breitz L, Brennan P, Crisp J, Etherton C, Ellis R, Feran K, Frazer E, Freiburger P, Garber K, Geekie M, Giedrys-Leeper E, Greenwall L, Grundy B, Heffernan M, Hetherington I, Hill G, Kidd A, Moxham D, Olesen N, Paolella T, Ro
Commercialism in marketing.
Br Dent J 2006 Feb 11;200(3):124-5
Link to source with long URL
HSL5306
Nystrand A.
[The examples Cancer Foundation, Heart-Lung foundation and Child Cancer Foundation: aggressive marketing undermines confidence].
Lakartidningen 2006 Feb 1-7;103(5):306-7
HSL5382
Nau JY.
[The OMS demands an immediate end to the commercialization of antimalarials only consisting of artemisinine].
Rev Med Suisse 2006 Feb 1;2(51):359
HSL5430
Shankar PR.
Always follow what you preach!
Acad Med. 2006 Feb 01;81(2):178
Link to source with long URL
HSL5753
Sarek M.
Evident exception in clinical practice not sufficient to break traditional hypothesis.
PLoS Med 2006 Feb 01;3(2):e120
Link to source with long URL
HSL5754
Rickels K.
Consumer advertising can be misleading.
PLoS Med 2006 Feb 01;3(2):e119
Link to source with long URL
HSL5755
McCarter G.
Should industry speak the loudest in informing the public on medical matters?
PLoS Med 2006 Feb 01;3(2):e118
Link to source with long URL
HSL5756
Oaks D.
Why did the FDA approve these advertisements?
PLoS Med 2006 Feb 01;3(2):e117
Link to source with long URL
HSL5990
Wilson N, Signal L, Nicholls S, Thomson G.
Marketing fat and sugar to children on New Zealand television.
Prev Med 2006 Feb 01;42(2):96-101
Link to source with long URL
HSL6853
Keng CJ, Lin HY.
Impact of telepresence levels on internet advertising effects.
Cyberpsychol Behav 2006 Feb 01;9(1):82-94
http://www.liebertonline.com/doi/abs/10.1089/cpb.2006.9.82
HSL5349
Panday S, Richter L, Bhana A.
Young adults, the target of below-the-line advertising.
S Afr Med J 2006 Feb;96(2):104-5
HSL5377
Murphy MT.
Is continuing education morphing into dental infomercials?
Dent Today 2006 Feb;25(2):12
HSL5432
Gardner MN, Brandt AM.
'The doctors' choice is America's choice': the physician in US cigarette advertisements, 1930-1953.
Am J Public Health 2006 Feb;96(2):222-32
http://www.ajph.org/cgi/content/full/96/2/222
HSL5433
MacLennan AH, Sturdee DW.
The 'bioidentical/bioequivalent' hormone scam.
Climacteric 2006 Feb;9(1):1-3
HSL5602
Sfikas PM.
Federal appeals court says no to first amendment claim in telemarketing case.
J Am Dent Assoc 2006 Feb;137(2):241-2
HSL5272
Jarhult B.
[Let the profit from drug advertisement in Lakartidningen go to a research foundation!].
Lakartidningen 2006 Jan 25-31;103(4):226
HSL5671
Friedman LS, Richter ED.
Excessive and disproportionate advertising in peer-reviewed journals.
Int J Occup Environ Health 2006 Jan-Mar 01;12(1):59-64
HSL6231
Sethi M, Mishra D.
Display of feeding bottles in advertising renditions.
Indian J Pediatr 2006 Jan 01;73(1):104-5
Link to source with long URL
HSL6395
De Santo NG.
[Promoting clinical research].
G Ital Nefrol 2006 Jan-Feb 01;23
HSL6892
O'Malley P.
Pharmaceutical advertising and clinical nurse specialist practice.
Clin Nurse Spec 2006 Jan-Feb 01;20(1):13-5
Link to source with long URL
HSL5308
Prescription for trouble: common drugs, hidden dangers Tens of people are at risk.
Consum Rep 2006 Jan;71(1):34-9
HSL5386
Finucane TE.
Advertising the new hypnotics.
J Am Geriatr Soc 2006 Jan;54(1):170
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2005.00575_1.x
HSL6744
Vandereycken W.
[Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry].
Tijdschr Psychiatr 2006;48(2):119-29
HSL6840
Wolfe SM.
Schroeder Lecture Worst pills, best pills.
Health Matrix Clevel 2006 Sum;16(2):785-96
HSL6093
Breggin PR
Court filing makes public my previously suppressed analysis of Paxil's effects.
Ethical Human Psychology and Psychiatry 2006 Spr;8(1):77-84
http://www.springerpub.com/
HSL6207
Rohra DK, Gilani AH, Memon IK, Perven G, Khan MT, Zafar H, Kumar R.
Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
J Pharm Pharm Sci 2006;9(1):50-9
http://www.ualberta.ca/~csps/JPPS9(1)/Rohra.D/promotion.htm
HSL6559
Davenport J.
Is your advertising a liability risk?
J N J Dent Assoc 2006 Spr;77(2):31
HSL6651
Liebenberg W.
Another white lie?
J Esthet Restor Dent 2006;18(3):155-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1708-8240.2006.00002.x
HSL6652
Manley PA.
Communicate first.
Mark Health Serv 2006 Sum;26(2):42
HSL6653
Cho H, Salmon CT.
Fear appeals for individuals in different stages of change: intended and unintended effects and implications on public health campaigns.
Health Commun 2006;20(1):91-9
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_9
HSL6731
Hullett CR.
Using functional theory to promote HIV testing: the impact of value-expressive messages, uncertainty, and fear.
Health Commun 2006;20(1):57-67
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_6
HSL6732
Polonec LD, Major AM, Atwood LE.
Evaluating the believability and effectiveness of the social norms message 'most students drink 0 to 4 drinks when they party'.
Health Commun 2006;20(1):23-34
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_3
HSL6733
Smith SW, Atkin CK, Roznowski J.
Are 'drink responsibly' alcohol campaigns strategically ambiguous?
Health Commun 2006;20(1):1-11
http://www.leaonline.com/doi/abs/10.1207/s15327027hc2001_1
HSL6787
Arden JD, Brensilver PC.
A bitter pill for plaintiffs: obstacles to market theories of causation in prescription drug consumer fraud cases.
Food Drug Law J 2006;61(3):539-46
HSL5510
Chepesiuk R.
Advertisement woes.
CMAJ 2005 Dec 6;173(12):1485
Link to source with long URL
HSL5678
Bednarik J.
Does brand differentiate pharmaceuticals?
Neuro Endocrinol Lett 2005 Dec 01;26(6):635-52
HSL5277
Katz KA.
AMEVIVE's advertisements: problematic?
Arch Dermatol 2005 Dec;141(12):1602-4
http://archderm.ama-assn.org/cgi/content/full/141/12/1602-a
HSL5222
Kirkwood L.
An artist's perspective on body image, the media, and contemporary society.
J Nutr Educ Behav 2005 Nov-Dec;37
HSL5608
Benedetti L.
We must find the problem in the intrinsic mechanisms of both media and medical research.
PLoS Med 2005 Oct;2(10):e364
Link to source with long URL
HSL5574
Mastroianni Pde C, Galduroz JC, Carlini EA.
Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom.
Sao Paulo Med J 2005 Sep 1;123(5):209-14
Link to source with long URL
HSL5249
Connolly M.
Keeping the boat afloat: tips on fundraising strategies for your chapter.
Imprint 2005 Sep-Oct;52(4):50-1
HSL5401
Cowin G.
Beware the language.
Aust Nurs J 2005 Sep;13(3):48
HSL5402
Richards D.
Real IR picture not in the advertising.
Aust Nurs J 2005 Sep;13(3):14
HSL4056
Burton B
US drug industry's guidelines on advertising too limited, say critics.
BMJ 2005 Aug 20;331(7514):420
Link to source with long URL
HSL5281
Duerksen SC, Mikail A, Tom L, Patton A, Lopez J, Amador X, Vargas R, Victorio M, Kustin B, Sadler GR.
Health disparities and advertising content of women's magazines: a cross-sectional study.
BMC Public Health 2005 Aug 18;5(85)
http://www.biomedcentral.com/1471-2458/5/85
HSL2485
Ruff TA, Haikal-Mukhtar H.
Doctors, drugs, information and ethics: a never-ending story.
Med J Aust 2005 Jul 18;183(2):73-4
http://www.mja.com.au/public/issues/183_02_180705/ruf10450_fm.html
HSL2266
Harvey KJ, Vitry AI., Aroni R, Ballenden N, Faggotter R.
Pharmaceutical advertisements in prescribing software: an analysis
MJA 2005 Jul 18;183(2):75-79
http://www.mja.com.au/public/issues/183_02_180705/har10263_fm.html
HSL4053
Croll TP, Swanson BZ Jr19th century dentistry.
Advertising trade cards.
J Hist Dent 2005 Jul 01;53(2):62
HSL6401
Cohen D.
Bold suggestion by Smith.
PLoS Med 2005 Jul 01;2(7):e226
Link to source with long URL
HSL6402
Sheldon T.
Focus on the funding and production of evidence rather than its publication.
PLoS Med 2005 Jul 01;2(7):e222
Link to source with long URL
HSL6403
Marcovitch H.
Little fish are less likely to take the bait.
PLoS Med 2005 Jul 01;2(7):e221
Link to source with long URL
HSL6405
Senn S.
Bitter pills and puffed trials.
PLoS Med 2005 Jul 01;2(7):e219
Link to source with long URL
HSL6406
Frighi V.
Medical journals, academia, and industry-sponsored clinical trials.
PLoS Med 2005 Jul 01;2(7):e218
Link to source with long URL
HSL4225
Timimi S.
Psychiatry has effectively become a commodity that is being sold to the drug industry.
Ment Health Today 2005 Jun 01;:21
HSL4265
Neville L, Thomas M, Bauman A.
Food advertising on Australian television: the extent of children's exposure.
Health Promot Int 2005 Jun 01;20(2):105-12
http://heapro.oxfordjournals.org/cgi/content/full/20/2/105
HSL6662
Brouneus F, Dahlin A, Beermann B.
Press coverage and sales of Xenical in Sweden, 1998-2000.
Eur J Clin Pharmacol 2005 Jun 01;61(4):285-9
http://www.springerlink.com/content/h74829p313380064/
HSL1780
Stafford A, Allen L.
Drug companies, doctors face curbs
The Financial Review 2005 May 10
HSL1783
Reuters .
Drug Makers Set Out to Create Ad Guidelines to Improve Image
REUTERS NEWS SERVICE 2005 May 10
HSL1853
Kaisernetwork.org
Prescription Drugs: PhRMA CEO Tauzin Discusses Drug Industry Image, Reimportation, Other Issues
kaisernetwork.org 2005 May 10
HSL1779
Reuters .
Regulator slaps Pfizer on Zoloft ads: FDA orders No. 1 drugmaker to halt ads neglecting to warn of antidepressant's fatal side effects.
CNN Money 2005 May 6
HSL1768
Dinant G-J, Mansfield P.
Van zoete koek naar gezonde scepsis: De houding van huisartsen tegenover geneesmiddelenreclame
Huisarts Wet 2005 May 2;48(6):304-307
Link to source with long URL
HSL5511
Smith R.
Medical journals are an extension of the marketing arm of pharmaceutical companies.
PLoS Med 2005 May 01;2(5):e138
Link to source with long URL
HSL4259
Warren CS, Strauss J, Taska JL, Sullivan SJ.
Inspiring or dispiriting? The effect of diet commercials on snack food consumption in high school and college-aged women.
Int J Eat Disord 2005 Apr 01;37(3):266-70
Link to source with long URL
HSL4258
Bloice C.
Why is this woman smiling? The hard sell of bad medicine.
Revolution 2005 Jan-Feb 01;6(1):22-9
HSL4187
Manchanda P, Honka E.
The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.
Yale J Health Policy Law Ethics 2005 Sum;5(2):785-822
HSL5332
Tomes N.
The great American medicine show revisited
Bull Hist Med. 2005 Winter;79(4):627-63 2005 Wint;79(4):627-63
Link to source with long URL
HSL5428
Caulfield T.
Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Health Law Rev 2005;13(2-3):58-61
HSL5625
Fernandez R, Gao C, Genkin W, Ghandi T, Graham R, Hou J, Hsu E, Hwang J.
Changing perspectives on dental advertising.
J Am Coll Dent 2005 Fall;72(3):24-6
HSL5626
Adamjee A, Alfi D, Agarwal D, Braithwaite Y, Chan J, Chey M, Cho H, Choi C.
What does the fact of advertising convey to patients?
J Am Coll Dent 2005 Fall;72(3):22-3
HSL2
Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18;329(7480):1487-8
Link to source with long URL
HSL2389
Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18;329(7480):1484-7
Link to source with long URL
HSL1722
Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A.
Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals.
Pharmacoepidemiol Drug Saf 2004 Nov;13(11):789-95
http://www3.interscience.wiley.com/cgi-bin/abstract/109712611/ABSTRACT
HSL2092
Ahmed SB, Grace SL, Stelfox HT, Tomlinson G, Cheung AM.
Gender bias in cardiovascular advertisements.
J Eval Clin Pract 2004 Nov;10(4):531-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2003.00483.x
HSL2093
Ahmed SB, Grace SL, Stelfox HT, Tomlinson G, Cheung AM.
Portrayal of female physicians in cardiovascular advertisements.
Can J Cardiol 2004 Nov;20(13):1351-4
HSL5393
Moynihan R.
The intangible magic of celebrity marketing.
PLoS Med 2004 Nov;1(2):e42
Link to source with long URL
HSL5312
Pai SA.
Publication ethics policies for medical journals.
Indian J Med Ethics 2004 Jul-Sep;1(3):93
HSL236
Burton B.
AstraZeneca digs in over advertising criticisms.
BMJ 2004 May 1;328(7447):1035
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1035-a
HSL6021
Mansfield PR.
Clarification and Update for AdWatch on Nexium dialogue
BMJ 2004 Apr 30;328
http://bmj.bmjjournals.com/cgi/eletters/328/7447/1035-a
HSL2486
Munce SE, Robertson EK, Sansom SN, Stewart DE.
Who is portrayed in psychotropic drug advertisements?
J Nerv Ment Dis 2004 Apr;192(4):284-8
Link to source with long URL
HSL243
Marco CA.
Pharmaceutical advertising in emergency departments.
Acad Emerg Med 2004 Apr;11(4):401-4
http://www.aemj.org/cgi/content/full/11/4/401
HSL281
Tuffs A.
Only 6% of drug advertising material is supported by evidence.
BMJ 2004 Feb 28;328(7438):485
http://bmj.bmjjournals.com/cgi/content/full/328/7438/485-a
HSL2696
Hemminki E, Karttunen T, Hovi SL, Karro H.
The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
Soc Sci Med 2004 Jan;58(1):89-97
Link to source with long URL
HSL2213
Kalb S.
[Influence of pharmaceutical advertising on the physician: A contribution to ethics in medicine].
Wurzbg Medizinhist Mitt 2004;23:446-56
HSL2785
Parojcic D.
[Patent medicines and its advertising in Serbia during the second half of the 19th and first half of the 20th century]
Rev Hist Pharm (Paris). 2004;52(342):229-46
HSL1413
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15;179(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html
HSL1427
Katz A.
Observations and advertising: controversies in the prescribing of hormone replacement therapy
Health Care Women Int 2003 Dec;24(10):927-39
HSL56
Wilde Mathews A, Steinberg B
FTC Examines Health Claims In KFC's Ads
The Wall Street Journal 2003 Nov 19
Link to source with long URL
HSL501
Sweet M.
Website launched to expose "tricks" of drug ads
BMJ 2003 Oct 18;327(7420):936
http://bmj.bmjjournals.com/cgi/content/full/327/7420/936
HSL1394
Richards D.
The problems and perils of prescription medicines.
Clin Med 2003 Sep-Oct;3(5):476-8
HSL1410
Mastroianni Pde C, Galduroz JC, Carlini EA.
Influence of the legislation on the advertisement of psychoactive medications in Brazil.
Rev Bras Psiquiatr 2003 Sep;25(3):146-55
HSL1038
Jureidini J, Mansfield P.
The journal and drug advertising.
Aust N Z J Psychiatry 2003 Aug;37(4):495
HSL5438
Kabra SG.
Unsafe abortions and experimental excesses.
Issues Med Ethics 2003 Jul-Sep 01;11(3):79-80
HSL1471
Bernardini C, Ambrogi V, Perioli L.
Drugs and non-medical products sold in pharmacy: information and advertising.
Pharmacol Res 2003 Jun;47(6):501-8
Link to source with long URL
HSL1453
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr;18(4):294-7
Link to source with long URL
HSL1384
Vilardell M.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361(9360):879
HSL1389
Simmonds H.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361(9360):878-9
Link to source with long URL
HSL1397
Peiró S, Librero J, Villanueva P, Inmaculad P.
Drug advertising in medical journals: Authors' reply
Lancet 2003 Mar 8;361(9360):878
HSL1412
Mansfield PR, Lexchin J, Vitry A, Doecke CJ, Svensson S.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361(9360):879
Link to source with long URL
HSL1416
Lopez-Gil A.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361(9360):877-8
Link to source with long URL
HSL1443
Ferner RE.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361(9360):879
Link to source with long URL
HSL1383
Villanueva P, Peiro S, Librero J, Pereiro I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 Jan 4;361(9351):27-32
http://linkinghub.elsevier.com/retrieve/pii/S0140673603121186
HSL1441
Fletcher RH.
Adverts in medical journals: caveat lector.
Lancet 2003 Jan 4;361(9351):10-1
Link to source with long URL
HSL1472
Batchlor E, Laouri M.
Pharmaceutical promotion, advertising, and consumers.
Health Aff (Millwood) 2003 Jan-Jun;Suppl
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.109v1
HSL1387
Tsai AC.
Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals.
Int J Health Serv 2003;33(4):751-68
HSL2854
James A.
Medicines, society, and industry.
Lancet 2002 Nov 2;360(9343):1346
Link to source with long URL
HSL1980
Shear NH.
Principles of influence.
CMAJ 2002 Sep 17;167(6):628
http://www.cmaj.ca/cgi/content/full/167/6/628
HSL2305
Newby DA, Henry DA.
Drug advertising: truths, half-truths and few statistics.
Med J Aust 2002 Sep 16;177(6):285-6
http://www.mja.com.au/public/issues/177_06_160902/new10443_fm.html
HSL2610
Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16;177(6):291-3
http://www.mja.com.au/public/issues/177_06_160902/lok10004_fm.html
HSL2306
Neumann PJ, Zivin Bambauer K, Ramakrishnan V, Stewart KA, Bell CM.
Economic messages in prescription drug advertisements in medical journals.
Med Care 2002 Sep;40(9):840-5
Link to source with long URL
HSL2254
Theroux R.
Bypassing the middleman: a grounded theory of women's self-care for vaginal symptoms.
Health Care Women Int 2002 Jul-Aug;23(5):417-31
Link to source with long URL
HSL2859
Hoye S, Hjortdahl P.
New wonder pill!--what do Norwegian newspapers write
2002 Jun 30;122(17):1671-6 2002 June 30;122(17):1671-6
Link to source with long URL
HSL2882
Dal-Pizzol F.
Drug advertisements in less-developed countries.
Lancet 2002 Apr 20;359(9315):1439-40
http://linkinghub.elsevier.com/retrieve/pii/S0140673602083836
HSL2567
Marinozzi S.
[Images of anti-luetic therapeutic systems and drugs].
Med Secoli. 2002;14(2):529-50
Link to source with long URL
HSL2289
Saumande P.
[About "Almanach de la Pharmacie Brunot", pharmaceutical advertising in "Limousin" at the beginning of the XXth century]
Rev Hist Pharm (Paris). 2002;50(335):451-60
Link to source with long URL
HSL2861
Hoogenberg K, van der Tuin J.
[Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
Ned Tijdschr Geneeskd. 2002 November 2;146(44):2099-100
Link to source with long URL
HSL2869
Graber MA, Weckmann M.
Pharmaceutical company internet sites as sources of information about antidepressant medications.
CNS Drugs 2002;16(6):419-23
Link to source with long URL
HSL2774
Newsweek 'adverzine'?
Consumers Union 2001 Dec:63
HSL2980
Bero L.
'Educational' advertisements - I haven't seen one yet!
Western Journal of Medicine 2001 Jun;174:395
HSL2952
Nucci C.
One hundred pennies for your thoughts (1st of 2 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1407
HSL2741
Lal A.
Pharmaceutical drug promotion: how it is being practiced in India?
J Assoc Physicians India 2001 Feb;49:266-73
HSL5440
Jesani A.
Calls for advertising and market reforms in health care.
Issues Med Ethics 2001 Jan-Mar;9(1):19
HSL5441
Mamdani B, Mamdani M.
Ethics of professional advertising.
Issues Med Ethics 2001 Jan-Mar;9(1):18
HSL5442
Malpani A.
Doctors should be allowed to advertise.
Issues Med Ethics 2001 Jan-Mar;9(1):16-7
HSL5443
Pandya SK.
Advertising remains unethical even in the digital age.
Issues Med Ethics 2001 Jan-Mar;9(1):15
HSL120
Vlassov V, Mansfield P, Lexchin J, Vlassova A.
Do drug advertisements in Russian medical journals provide essential information for safe prescribing?
West J Med 2001;174:391-394
Nil
HSL2998
Sams WM, Freedberg IM.
The dermatology-industry interface: defining the boundaries.
J Am Acad Dermatol 2000 Sep;43(3):550-4
Link to source with long URL
HSL3041
Miller P.
Is academic medicine for sale? (12th of 13 letters)
New England Journal of Medicine 2000 Aug 17;343(7):510
http://content.nejm.org/cgi/content/full/343/7/508
HSL3039
Montauk L.
Medical junk mail.
Lancet 2000 Jul 22;356(9226):344
HSL2988
Wazana A.
Gifts to physicians from the pharmaceutical industry [1st of 2 replies]
JAMA 2000 May 24-31;283(20):2675
HSL343
Lovdahl U, Riska E.
The construction of gender and mental health in Nordic psychotropic-drug advertising.
Int J Health Serv 2000;30(2):387-406
Nil
HSL2406
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin; 2000
Link to source with long URL
HSL3003
Roughead L, Gilbert A.
Medicines and the media
Australian Prescriber 2000;23(6):115
http://www.australianprescriber.com
HSL7518
Ala-fossi N, Vilhunen S, Lilja J, Enlund H.
Promoting antidepressants to physicians in Finnish direct mail and journal advertisements
Journal of Social and Administrative Pharmacy 2000;17:9-14
HSL8518
Nolan A.
Pharmaceutical advertising in clinical software
Australian Prescriber 2000;23(3):52-53, 67
HSL8519
Letendre W, Jackson R.
Marketing your prescription compounding practice. Part 3
International Journal of Pharmaceutical Compounding 2000;4(3):199-202
HSL2727
Wang TJ, Ausiello JC, Stafford RS.
Trends in antihypertensive drug advertising, 1985-1996.
Circulation 1999 Apr 20;99(15):2055-7
http://circ.ahajournals.org/cgi/reprint/99/15/2055
HSL2709
Jones , M. , Greenfield , S. , Bradley , C
A survey of the advertising of nine new drugs in the general practice literature.
Journal of Clinical Pharmacy and Therapeutics 1999;24:451-460
http://www.blackwell-synergy.com/doi/full/10.1046/j.1365-2710.1999.00255.x
HSL536
Lal A.
Information contents of drug advertisements: an Indian experience.
Ann Pharmacother 1998 Nov;32(11):1234-8
http://www.theannals.com/cgi/reprint/32/11/1234
HSL742
Alliot L.
Quality of drug advertisements in medical journals.
Lancet 1997 Nov 29;350(9091):1636
HSL560
Vitry A, Mansfield P.
Drug advertisements in medical journals.
Lancet 1997 Nov 15;350(9089):1477-8
Link to source with long URL
HSL714
Hueston WJ, Mainous AG 3rd.
A comparison of the numbers of pharmaceutical advertising pages in family medicine research journals and journals in other medical disciplines.
Acad Med 1997 Sep;72(9):804-6
HSL723
Gitanjali B, Shashindran CH, Tripathi KD, Sethuraman KR.
Are drug advertisements in Indian edition of BMJ unethical?
BMJ 1997 Aug 23;315(7106):459
http://www.bmj.com/cgi/content/full/315/7106/459
HSL733
Christo GG, Balasubramaniam R.
Commentary: advertising adversities.
BMJ 1997 Aug 23;315(7106):460
http://www.bmj.com/cgi/content/full/315/7106/460
HSL688
Rapp MS.
Can drug companies have it both ways?
CMAJ 1997 Apr 1;156(7):982-3
http://www.cmaj.ca/cgi/reprint/156/7/982
HSL710
Lal A, Moharana AK, Srivastava S.
Comparative evaluation of drug advertisements in Indian, British and American medical journals.
J Indian Med Assoc 1997 Jan;95(1):19-20
HSL685
Reid T.
Onsert with Canadian Family Physician questionable.
Canadian Family Physician 1997;43:613
Nil
HSL689
Quinn J, Nangle M, Casey PR.
Analysis of psychotropic drug advertising
Psychiatric Bulletin 1997;21:597-99
Nil
HSL697
Mansfield P, Lexchin J.
MaLAM: networking for scientific integrity in drug promotion.
Essential Drugs Monitor 1997(24):5
http://healthyskepticism.org/library/EDM/24/Page5.pdf
HSL706
Lexchin J.
Recent progress in drug advertising
Can Fam Physician 1997;43:1041-1042
HSL713
Additional statements from the International Committee of Medical Journal Editors.
CMAJ 1997;156(4):571-8
http://www.cma.ca/cmaj/vol-156/issue-4/0571.htm
HSL743
Wolfe S.
Drug advertisements and prescribing
Lancet 1997;348:1452-1453
HSL1885
Suryawati S, Santoso B.
Drug advertisements: A critical lesson for Indonesian students
Essential Drugs Monitor 1997;23:23
http://www.who.int/medicines/library/monitor/edm_23_e.pdf
HSL804
Angel JE.
Drug advertisements and prescribing.
Lancet 1996 Nov 23;348(9039):1452-3
HSL778
Lal A, Moharana AK, Chandra P, Ray A.
Critical evaluation of references in drug advertisements: an Indian experience.
J Assoc Physicians India 1996 Nov;44(11):778-9
HSL798
Dikshit RK, Dikshit N.
What information is available on request from drug advertisers in India?
BMJ 1996 Oct 5;313(7061):855-6
http://www.bmj.com/cgi/content/full/313/7061/855
HSL744
Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7;348(9028):632
Nil
HSL762
Rothermich EA, Pathak DS, Smeenk DA.
Health-related quality-of-life claims in prescription drug advertisements.
Am J Health Syst Pharm 1996 Jul 1;53(13):1565-9
HSL758
Soltan HC.
Violence sells.
CMAJ 1996 Mar 15;154(6):756,
HSL1895
Coulter RH, Pinto MB.
Guilt appeals in advertising: what are their effects?
J Appl Psychol 1995 Dec;80(6):697-705
http://content.apa.org/journals/apl/80/6/697
HSL1712
Brodie MJ, Pellock JM.
Taming the brain storms: felbamate updated.
Lancet 1995 Oct 7;346(8980):918-9
HSL833
Mabin DC.
BMJ should declare its own conflict of interest.
BMJ 1995 Sep 30;311(7009):878-9
http://www.bmj.com/cgi/content/full/311/7009/878/b
HSL814
Wilkes MS, Kravitz RL.
Policies, practices, and attitudes of North American medical journal editors.
J Gen Intern Med 1995 Aug;10(8):443-50
HSL830
Nikelly AG.
Drug advertisements and the medicalization of unipolar depression in women.
Health Care Women Int 1995 May-Jun;16(3):229-42
HSL2427
Ogilvy D.
Ogilvy on advertising.
London: Prion; 1995
http://www.randomhouse.com/vintage/catalog/display.pperl?isbn=9780394729039
HSL818
Taylor SD, Sullivan DL, Birdwell SW.
A comparative analysis of prescription drug advertising before and after patent expiration
J Pharm Mark Manage 1995;9(4):3-18
HSL827
Rapoport D.
Under the influence of the pharmaceutical industry? Kick the habit.
CMAJ 1995;152:1043
HSL835
Landefeld CS, Chren MM, Siddique RM.
A 4-year study of the volume of drug advertisements in leading medical journals
N Engl J Med 1995;10(Supp):111
HSL846
Hansen FJ, Osborne D.
Portrayal of women and elderly patients in psychotropic drug advertisements
Women & Therapy 1995;16:129-141
HSL1715
Beales JH 3rd, MacLeod WC.
Assessments of pharmaceutical advertisements: a critical analysis of the criticism.
Food Drug Law J 1995;50(3):415-49
HSL2419
Ferner RE, Scott DK.
Whatalotwegot--the messages in drug advertisements.
BMJ 1994 Dec 24-31;309(6970):1734-6
http://www.bmj.com/cgi/content/full/309/6970/1734
HSL7046
Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar;37(3):217-9
Nil
HSL840
Kessler DA, Rose JL, Temple RJ, Schapiro R, Griffin JP.
Drug promotion.
N Engl J Med 1994;331(10):1350
HSL2693
Engle , R .
The Impact of a Single-Advertiser Publication on Physicians’ Perceptions and Expected Prescribing Behaviour.
Journal of Pharmaceutical Marketing and Management 1994;8(1):37-54
Nil
HSL6277
Beales JH.
Economic analysis and the regulation of pharmaceutical advertising
Seaton Hall Law Review 1994;24:1370-1398
HSL6279
Beazley GP.
Size of names in drug ads
Canadian Medical Association Journal 1994;151:1113
HSL6285
Chetley A.
Generic embarrassment
Lancet 1994;343:1089-1090
HSL6286
Chirac P.
Control of drug advertising in France: a poor example
Prescrire International 1994;3(13):145-147
HSL6287
Chirac P.
Drug advertising must be more strictly controlled
Prescrire International 1994;3(13):160
HSL6470
Engle R.
The impact of a single-advertiser publication on physicians’ perceptions and expected perscribing behavior
Journal of Pharmaceutical Marketing & Management 1994;8(1):37-54
HSL6604
Huston P.
Advertising in medical journals
Canadian Medical Association Journal 1994;151:7
HSL6605
Advertising in medical journals
Canadian Medical Association Journal 1994;150:27
HSL6606
Advertising in medical journals and the use of supplements
Canadian Medical Association Journal 1994;151:527
HSL6607
Jacoby J.
Misleading research on the subject of misleading advertising: the Wilkes et al. investigation of pharmaceutical advertising in leading medical journals
Food and Drug Law Journal 1994;49:21-33
HSL5699
Mann J, Crooke M, Fear H, Hay D, Jackson R, Neutze J, White H.
Pharmaceutical company sponsorship.
N Z Med J 1993 Jul 28;106(960):318
HSL5198
Hogan DJ, Sarel D, Canas A, Bellman B, Eaglstein W, Hogan LA, Kramer J.
An analysis of advertisements in the Journal of the American Academy of Dermatology, 1980 and 1990.
J Am Acad Dermatol 1993 Jun;28(6):993-7
HSL5701
Massam D.
Unpublished data in drug advertisements.
BMJ 1993 Apr 24;306(6885):1127
HSL5697
Lober CW.
Ethics in pharmaceutical advertising.
Dermatol Clin 1993 Apr 01;11(2):285-8
HSL5791
Sommers E.
Drug advertising
Canadian Medical Association Journal 1993;146:1230
HSL2141
Ranwella S.
Sri Lankan students campaign for rational medicine: the story of SIRHA.
Essent Drugs Monit 1993(16):10
HSL5774
Millstein LG.
Deceptive x-ray films in an advertisement
New England Journal of Medicine 1993;329:1207
HSL5776
Morrissy J.
Pharmaceutical ads under editorial control: is it necessary?
Canadian Family Physician 1993;39:1325
HSL5148
World Health Organization
FDA acts against misleading marketing of osalazine
Essential Drugs Monitor 1993(16):3
HSL5153
Ahmad SR.
Misleading advertising of Zantac
Lancet 1993;341:748
HSL5154
Alden , Errol R., Dow J
Advertising in Pediatrics
Pediatrics 1993;92(4):610
HSL5164
Bentley , Marjorie .
Drug advertising requires special rules for a special marke
CMAJ 1993;149:209-210, 212
HSL5165
Bero L, Galbraith A, Rennie D
Publication of sponsored symposiums in medical journals
New England Journal of Medicine 1993;328:1197-1198
HSL5166
Boer , A .
Pharmaceutical advertising in medical journals
JAMA 1993;268:147-148, 151
HSL5169
Brodie-brown , W. F.
Pharmaceutical ads under editorial control: is it necessary. Response
Canadian Medical Association Journal 1993;39:1325
HSL5185
Editor .
Drug advertisements
BMJ 1993;306:720
HSL5196
Hawkins J, Aber C, .
Women in advertisements in medical journals
Sex Roles 1993;28:233-242
HSL5197
Herxheimer A, Lundborg CS, Westerholm B.
Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards.
Int J Health Serv 1993;23(1):161-72
HSL5547
Krause J, Nour Eldin.
Ethical criteria and pharmaceutical advertising
Drugs made in Germany 1993;36(3):78-90
HSL5551
Leppard W, Ogletree SM, Wallen E.
Gender stereotyping in medical advertising: much ado about something?
Sex Roles 1993;29:829-838
HSL5698
Makkonen K.
Problems in distribution of scientific knowledge: intrauterine contraceptive devices and drug catalogs.
Int J Health Serv 1993;23(1):173-83
HSL6061
Squires BP.
Truth in advertising
Canadian Medical Association Journal 1993;148:1663
HSL6070
Wakefield IR.
Pharmaceutical company sponsorship
New Zealand Medical Journal 1993;106:232
HSL6097
Keen PJ.
Pharmaceutical advertising controls - the future
Journal of the Royal Society of Medicine 1993;86:237-239
HSL5137
Shapiro MF.
Critics dissect, authors defend Wilkes paper on advertising [author's response]
Medical Marketing & Media 1992 Dec 1;27(12):18-19
HSL5143
Organon, the IFPMA Code and the WHO Ethical Criteria
MaLAM International Newsletter 1992 Dec:1-2
HSL5142
New code workshop
PMAC Bulletin 1992 Nov 30;15(92):6-9
HSL5134
Jacoby , J .
Critics dissect, authors defend Wilkes paper on advertising [1st of 4 critiques]
Medical Marketing & Media 1992 Nov 5;27(12):16-17
HSL5133
Castagnoli , William G.
Critics dissect, authors defend Wilkes paper on advertising
Medical Marketing & Media 1992 Nov 1;27(12):14-20, 22
HSL5135
Rubin , Paul H.
Critics dissect, authors defend Wilkes paper on advertising [3rd of 4 critiques]
Medical Marketing & Media 1992 Nov 1;27(12):17-18
HSL5136
Schmittlein , David .
Critics dissect, authors defend Wilkes paper on advertising [2nd of 4 critiques]
Medical Marketing & Media 1992 Nov 1;27(12):17
HSL5139
Wilkes MS.
Critics dissect, authors defend Wilkes paper on advertising [summary of the research]
Medical Marketing & Media 1992 Nov 1;27(12):15-16
HSL4988
Chetley A.
Promoting health or pushing drugs?
HAI News 1992 Oct(67):1-2, 10-12
HSL4989
Preuss K.
New approaches to promotion in the EC
Scrip Magazine 1992 Oct(8):23-26
HSL4980
Schwartz H.
The medical journals and drug advertising—the Schwartz view
Scrip Magazine 1992 Jul-Aug(6):15-16
HSL4975
Cowley G.
Not what the doctor ordered: a study criticizes drug ads in medical journals
Newsweek 1992 Jun 9:54
HSL2412
Wilkes MS, Doblin BH, Shapiro MF.
Pharmaceutical advertisements in leading medical journals: experts' assessments.
Ann Intern Med 1992 Jun 1;116(11):912-9
Nil
HSL3134
Kline S.
Prescription drug advertising: Communicating risk, benefit and cost of pharmaceuticals
Canadian Public Health Association 1992 Feb 2-4:52-6
HSL4779
Adams DG.
Pharmaceutical advertising: Education versus promotion
Journal of Pharmaceutical Marketing & Management 1992;7(1):53-66
HSL4782
Almarsdottir AB, Bush PJ.
The influence of drug advertising on children’s drug use attitudes and behaviors
Journal of Drug Issues 1992;22:361-376
HSL4804
Caudill TS, Lurie N, Rich EC.
The influence of pharmaceutical industry advertising on physician prescribing
Journal of Drug Issues 1992;22:331-338
HSL4810
Cope JD.
Nonprescription drugs and the regulation of advertising
Journal of Drug Issues 1992;22:257-264
HSL4812
Cundy T.
Medical junk mail
New Zealand Medical Journal 1992;105:437
HSL4815
Demarco T.
Should physicians pay for medical journals
Canadian Family Physician 1992;38:1769
HSL4817
Ende M.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1687
HSL4818
Ferner RE, Scott DK.
The nature and content of advertisements for medicines
British Journal of Clinical Pharmacology 1992;34:158P
HSL4819
Fink E, Antonelli MA.
Pharmaceutical ads in Annals
Annals of Internal Medicine 1992;116:958
HSL4828
Goertzen J.
Inappropriate layout?
Canadian Family Physician 1992;38:1769
HSL4830
Gurnee MC, Hansen JM, Sylvestri MF.
Portrayal of the elderly in drug product advertisements: Relationship to dosing recommendations and pharmacokinetic data in the geriatric population
Journal of Pharmaceutical Marketing & Management 1992;72:17-31
HSL4835
Imperato JP.
Pharmaceutical advertising in the Journal
New England Journal of Medicine 1992;327:1688
HSL4839
Kassirer JP.
Pharmaceutical advertising in the Journal
New England Journal of Medicine 1992;327:1689
HSL4845
Krinksy DL.
Pharmaceutical ads in journals
Annals of Internal Medicine 1992;117:618
HSL4846
Krupka LR, Vener AM.
Gender differences in drug (prescription, non-prescription, alcohol and tobacco) advertising: trends and implications
Journal of Drug Issues 1992;22:339-360
HSL4860
Menkes DB.
Medical junk mail
New Zealand Medical Journal 1992;105:437
HSL4862
Montagne M.
Drug advertising and promotion: an introduction
Journal of Drug Issues 1992;22:195-203
HSL4866
Mossinghoff GJ.
Pharmaceutical manufacturers and self-regulation of drug advertising and promotion
Journal of Drug Issues 1992;22:235-243
HSL4869
Narini P.
Advertising benefits journal readers
Canadian Family Physician 1992;38:1293
HSL4891
Peeler CL.
Pharmaceutical advertising: A Federal Trade Commission perspective
Journal of Pharmaceutical Marketing & Management 1992;7(1):157-167
HSL4895
Reynolds WJ.
Trends in advertising pharmaceuticals: A publisher's perspective
Journal of Pharmaceutical Marketing & Management 1992;7(1):5-22
HSL4900
Rubenstein DS.
Pharmaceutical ads in Annals
Annals of Internal Medicine 1992;116:958
HSL4902
Inappropriate layout?
Canadian Family Physician 1992;38:1769
HSL4903
Seaver PR.
Prescription drug advertising: An industry perspective
Journal of Pharmaceutical Marketing & Management 1992;7(1):33-41
HSL4909
Sorofman B.
Drug promotion in self-care and self-medication
Journal of Drug Issues 1992;22:377-388
HSL4911
Squires BP.
Drug information discrepancy
Canadian Medical Association Journal 1992;147:584, 588
HSL4912
Stallings S.
From printing press to pharmaceutical representative: a social history of drug advertising and promotion
Journal of Drug Issues 1992;22:205-219
HSL4914
Taibleson DE.
Pharmaceutical advertising in the Journal
New England Journal of Medicine 1992;327:1688
HSL4920
Vandewall J.
New directions in pharmaceutical advertising
Journal of Pharmaceutical Marketing and Management 1992;7(1):75-86
HSL4923
Voth AJ.
Pharmaceutical ads in Annals
Annals of Internal Medicine 1992;116:958
HSL4924
Waldholz MR.
Prescription drug advertising: A critic's perspective
Journal of Pharmaceutical Marketing & Management 1992;7(1):43-52
HSL4934
Wilkes MS, Doblin BH, Shapiro MF.
Pharmaceutical ads in journals
Annals of Internal Medicine 1992;117:618-619
HSL4775
Suryawati S, Santoso B.
Drug promotion: two views. Indonesia
INRUD News 1991 Dec;2(2):3
HSL2073
Goodfriend TL.
Using pharmaceutical advertising in medical education.
Acad Med 1991 Feb;66(2):122
HSL2407
Mansfield PR.
Classifying improvements to drug marketing and justifications for claims of efficacy.
Int J Risk Safety Med 1991;2:171-84
Nil
HSL4643
Barrett J.
Cost-effectiveness in advertising
Lancet 1991;338:699-700
HSL4649
Clairman A.
Junk mail reduction
Canadian Family Physician 1991;37:282
HSL4650
Clearwater G.
Advertising junk mail
New Zealand Medical Journal 1991;104:344
HSL4657
Garattini S.
An end to the fun and games?
Lancet 1991;338:749-750
HSL4661
Goldstein JH.
Doctoring medicine: reading between the lines of drug advertisements
Journal of Medical Humanities 1991;12(2):73-83
HSL4663
Harvey K, Mansfield P.
Drug promotion: the critical approach
Australian Prescriber 1991;14(1):34-35
HSL4664
Herxheimer A, Lundborg CS, Westerholm B.
Advertisements for medicines in medical journals: a collaborative international study
1991
HSL4681
Mansfield PR.
Encouraging drug companies to be honest
Australian Prescriber 1991;14:74
HSL4710
Squires BP.
PAAB: a lesson in self-government
Canadian Medical Association Journal 1991;144:844-845
HSL6315
Kilbourne WE.
Perceptual biases in affirmative disclosures in print ads: Practical and public policy implications
Journal of Business Research 1990 Sep 1;21(2):131-141
HSL4631
Saade C, Huff-rousselle M.
Pakistan: should ORS be marketed like other drugs?
Dialogue on Diarrhoea 1990 Sep(42):6
HSL2162
Ferguson RP.
Teaching medical residents critical analysis of pharmaceutical promotional material.
Del Med J 1990 Jul;62(7):1127-9
HSL4500
Ahmad SR, Bhutta ZA.
A survey of pediatric prescribing and dispensing in Karachi
Journal of the Pakistan Medical Association 1990;40:126-130
HSL4513
Blouin , C .
Hypertension and eating habits
Canadian Medical Association Journal 1990;143:460-461
HSL4523
Cockerill R.
Report on the 1989 survey of the dispensing practices and attitudes toward prescription drugs of Ontario pharmacists
1990
HSL4525
Double standard labelling of pharmaceuticals sold in Thailand
Drug Study Group 1990:3
HSL4526
Duffin JM.
Junk mail
Canadian Medical Association Journal 1990;142:708
HSL4529
Feather KR.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:659
HSL4535
Gorski TN.
Doctors, drug companies, and gifts
JAMA 1990;263:2177
HSL4538
Herxheimer A.
Medicines in francophone Africa
Lancet 1990;335:1449-1450
HSL4541
Jason KM.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:658-659
HSL4545
Kimbel KH.
Advertorials?
Lancet 1990;336:496
HSL4548
Lexchin J.
The portrayal of the elderly in drug advertisements: a factor in inappropriate prescribing?
Canadian Journal on Aging 1990;9:296-303
HSL4555
Morris LA, Banks DB.
New issues in drug advertising and labeling: the five advertising end-runs
Drug Information Journal 1990;24:639-646
HSL4568
Relman AS.
More on sex and racial bais in pharmaceutical advertisements
New England Journal of Medicine 1990;322:1534
HSL4571
Robertson WO.
Throw-away journals
Canadian Medical Association Journal 1990;142:708
HSL4584
Shepherd R.
Junk mail
Canadian Medical Association Journal 1990;143:14
HSL4589
Squires BP.
Editors and advertisers
Canadian Medical Association Journal 1990;143:167
HSL4590
Squires BP.
PAAB: a lesson in self-government
Canadian Medical Association Journal 1990;143:1151
HSL4597
Tilyard MW, Dovey SM.
Placement of advertisements
New Zealand Medical Journal 1990;103:382
HSL4605
Williams EB.
Advertising acyclovir
Lancet 1990;335:288
HSL4611
Cohen EP.
Are pharmaceutical ads good medicine?
Business and Society Review 1990;73:8-10
HSL4620
Hamer P.
More medication for healthy women!
DES Action Canada Newsletter 1990(23):1-2
www.web.net/~desact
HSL4457
Wade VA, Mansfield PR, McDonald PJ.
Drug companies' evidence to justify advertising.
Lancet 1989 Nov 25;2(8674):1261-3
HSL4490
Cearnal ME.
Journal advertising works
Medical Marketing & Media 1989 Oct 20;24(12):4,6-10
HSL1035
Mansfield PR.
Drug advertising.
Lancet 1989 May 20;1(8647):1137-8
HSL4469
Logarta JD.
Generics revisited: an overdose of expectations
Drug Monitor 1989 Apr;4(4):49-54
HSL4127
Birley JL.
Drug advertisements in developing countries.
Lancet 1989 Jan 28;1(8631):220
HSL4461
Highlights of a survey of Southeast Asian physicians
Drug Monitor 1989 Jan;4(1):8
HSL4130
Burton JL.
Baldness and minoxidil advertising
Lancet 1989;1:442-443
HSL4410
Fogel ML.
Survey of pharmaceutical promotion in a family medicine training program
Canadian Family Physician 1989;35:1603-1605
HSL4419
The effect of journal advertising on market shares of new prescriptions
1989
HSL4446
Rachlis M, Kushner C.
Second opinion: what’s wrong with Canada’s health-care system and how to fix it
1989
HSL4015
Lexchin J.
Antihypertensive drugs and advertising.
N Z Med J 1988 Nov 23;101(858):805
HSL4105
Mann CC, Plummer ML.
The big headache
Atlantic Monthly 1988 Oct:39-46, 48-49, 52-57
HSL4106
Mitchell JF, Pawlicki KS.
"Dispense as written" advertisements are demeaning to pharmacists.
Am J Hosp Pharm 1988 Oct;45(10):2073
HSL4034
Potter HP Jr.
Costs of drug advertising.
N Engl J Med 1988 Sep 22;319(12):798
HSL4068
Shaughnessy AF.
Drug promotion in a family medicine training center.
JAMA 1988 Aug 19;260(7):926
HSL4076
Vo-kyung S, Ok KIM.
Investigation of the violations of pharmaceutical regulations in advertisements of children’s medicines
1988 Aug 18-20
HSL4066
Seibel J, Levitz SM.
Minorities in the Journal's advertisements.
N Engl J Med 1988 Jul 7;319(1):57-8
HSL4088
Healthcare communications and pharmaceutical promotion
Health Horizons 1988 May(4):16-17
HSL1040
Mansfield P.
Diflunisal advertising.
Med J Aust 1988 Apr 18;148(8):418,
HSL4085
Anstice DW.
Diflunisal advertising [2nd of 2 replies]
Medical Journal of Australia 1988 Apr 18;148:418, 420
HSL4064
Rubin JN, Widerhorn J, Elkayam U.
Nitroglycerin tolerance.
N Engl J Med 1988 Jan 14;318(2):120
HSL3985
International medical advertising
Lancet 1988;1:350
HSL3989
An unscrupulous advertisement
Lancet 1988;1:1098
HSL3990
Baldini R.
Nitroglycerin tolerance
New England Journal of Medicine 1988;318:120
HSL3995
Collier J, Herxheimer A.
Medicines Act passes crucial test
Lancet 1988;1:1349
HSL4000
Harvey K.
The influence of advertising over prescribing
Australian Journal of Hospital Pharmacy 1988;18(3):25-28
HSL4001
Hawkins JW, Aber CS.
The content of advertisements in medical journals: distorting the image of women.
Women Health 1988;14(2):43-59
HSL4003
Heilman SR.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL4017
Lexchin J.
Pharmaceutical promotion in New Zealand.
Community Health Stud 1988;12(3):264-72
HSL4024
Mossinghoff GJ.
Costs of drug advertising
New England Journal of Medicine 1988;319:798
HSL4030
Pearse WH.
Advertising of prescription drugs
New England Journal of Medicine 1988;319:314
HSL4060
Relman AS.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53-54
HSL4061
Relman AS.
Minorities in the Journal’s advertisements
New England Journal of Medicine 1988;319:58
HSL4065
Schiedermayer , McKinney WP.
The Feldene connection: drug dealing in the doctors’ parking lot?
New England Journal of Medicine 1988;319:1291-1292
HSL4070
Sterky G, Tomson G, Sachs L, Henningsson B, Bergman U.
Medicines and society: a challenge in health development
1988
HSL4083
Scott JE.
Ad performance insights
Medical Marketing & Media 1988;23(2):32, 34, 36
HSL4086
Bell KD.
Diflunisal advertising [1st of 2 replies]
Medical Journal of Australia 1988;148:418
HSL4104
Hardon A.
Towards rational drug-use in urban primary health care
Drug Monitor 1988;3(10):111-119
HSL3981
Bell KD.
Drug advertising.
Med J Aust 1987 Oct 5;147(7):361
HSL3982
Wing LM, Moulds RF, Shenfield GM, Day RO.
Drug advertising [reply]
Medical Journal of Australia 1987 Oct 5;147:361
HSL3875
Finucane T.
Drug company-sponsored symposia: pros and cons.
Am J Med 1987 Oct;83(4):811-2
HSL3980
Advertisement of Rx drugs to health professionals
1987 Oct:17
HSL3772
Carter IE.
Canadian Psychiatric Association guidelines in relating to the pharmaceutical industry.
Can J Psychiatry 1987 Aug;32(6):476-86
http://www.cpa-apc.org/Publications/Position_Papers/Guideline.asp
HSL3970
DOH proposes regulating of drug ads
Drug Monitor 1987 Aug;2(8):3-5
HSL3973
Organon and anabolic steroids
WEMOS pharma group 1987 Aug
HSL3968
Juergens JP.
Advertising in the American Journal of Hospital Pharmacy.
Am J Hosp Pharm 1987 Jul;44(7):1647-51
HSL3969
Zellmer WA.
Prudent and sensible advertising policies.
Am J Hosp Pharm 1987 Jul;44(7):1651-3
HSL2408
Mansfield PR.
Drug Advertising
Med J Aust 1987 Jun 15;146(12):660-661
HSL3901
Lexchin J.
Advertisement scrutiny.
Lancet 1987 Jun 6;1(8545):1323-4
HSL3917
Speller DC.
The relationship between the Journal and the pharmaceutical industry.
J Antimicrob Chemother 1987 Jun;19(6):711-2
HSL3964
MaLAM letter follow up—Janssen
MaLAM Newsletter 1987 Jun:1-2
HSL3879
Godden JO.
Monitoring drug advertisements.
Lancet 1987 Apr 25;1(8539):980
HSL3959
Dyer C.
The penalties of issuing misleading advertisements.
Br Med J (Clin Res Ed) 1987 Feb 14;294(6569):426-7
HSL3960
Editor .
The penalties of issuing misleading advertisements [Editor's response]
British Medical Journal 1987 Feb 14;294:427
HSL2414
Hutcheon L, Hutcheon M.
Medical “mythologies”: a semiotic approach to pharmaceutical advertising.
Queen's Q 1987;94:904-16
Nil
HSL3863
Conviction for breach of Medicines Act in drug advertisement
Lancet 1987;1:57
HSL3866
Roussel appeal against advertisement decision
Lancet 1987;1:233
HSL3867
Bennett JC.
The reply
American Journal of Medicine 1987;83:812
HSL3876
Fisherow WB.
The shape of prescription drug advertising: a survey of promotional techniques and regulatory trends
Food Drug Cosmetic Law Journal 1987;42:213-236
HSL3882
Gray BV.
Drug promotion
New Zealand Medical Journal 1987;100:754
HSL3891
Hutcheon L, Hutcheon M.
Medical “mythologies”: a semiotic approach to pharmaceutical marketing
Queen’s Quarterly 1987;94(4):904-916
HSL3903
Lexchin J.
Pharmaceutical promotion in Canada: convince them or confuse them.
Int J Health Serv 1987;17(1):77-89
HSL3907
Moulds RF, Wing IM, Shenfield GM, Day RO.
Drug advertising
Medical Journal of Australia 1987;147:160
HSL3924
Vere DW.
Advertising claims and the Medicines Act
Lancet 1987;1:278
HSL3855
Doctors and the drug industry [Editor's response to 3rd letter (O'Dowd & Whibley)]
British Medical Journal 1986 Nov 1;293:1171
HSL3854
Ford AR.
“When women outlive their ovaries”
New Internationalist 1986 Nov(165):12-13
HSL3848
Lexchin J.
Good health?
New Outlook 1986 Sep-Oct:24-26, 28-31
HSL3786
Holmes J, Hornblow A, Logan W, Botting C, Wells E, Tan SP, Chetwynd J, Frampton C.
Offensive advertising?
N Z Med J 1986 Aug 27;99(808):641-2
HSL3825
St George D.
Life expectancy, truth, and the ABPI.
Lancet 1986 Aug 9;2(8502):346
HSL3813
Moulds RF, Bochner F, Wing LM.
Drug advertising.
Med J Aust 1986 Aug 4-18;145(3-4):178-9
HSL1041
Mansfield P.
Phenylbutazone.
Med J Aust 1986 Jan 6;144(1):55
HSL2413
Goldman R, Montagne M.
Marketing 'mind mechanics': decoding antidepressant drug advertisements.
Soc Sci Med 1986;22(10):1047-58
Nil
HSL3763
Bearn AG.
Should a drug company employee edit a medical journal?
Lancet 1986;1:974
HSL3769
Cairns L.
Offensive advertising?
New Zealand Medical Journal 1986;99:641-642
HSL3773
Cohen RL.
Drug companies and journal supplements
Lancet 1986;1:1157
HSL3775
Comanor WS.
The political economy of the pharmaceutical industry.
J Econ Lit 1986;24(3):1178-1217
HSL3776
Drugs and the Third World: chloroform sale and hazards—a Malaysian study
Consumers’ Association of Penang 1986
HSL3793
Lapinski F.
Omission of women and black physicians from Journal ads
New England Journal of Medicine 1986;314:653
HSL3808
McGovern I.
Advertising and benzodiazepines
Medical Journal of Australia 1986;145:179
HSL3831
Woods D.
Annual report to the readers
Canadian Medical Association Journal 1986;134:7
HSL3861
Collier J.
Promotion of medicines—the failure of regulation
Medicine in Society 1986;12(3):8-10
HSL3729
Osiobe SA.
Sources of information for biomedical decision-making.
Methods Inf Med 1985 Oct;24(4):225-9
HSL3734
Weissel JR.
Australian pharmaceutical advertising: the industry's view.
Med J Aust 1985 Sep 30;143(7):274-5
HSL1042
Mansfield P.
Phenylbutazone.
Med J Aust 1985 Sep 2;143(5):219-20
HSL3717
Kaplan NM.
Educating physicians in the use of pharmaceuticals.
Circulation 1985 Aug;72(2)
HSL3741
Sivarajan M.
Tarnishing the medical profession's image.
N Engl J Med 1985 Apr 25;312(17):1132
HSL3707
Bateman DN.
Ethics of drug marketing
Lancet 1985;1:166
HSL3708
Benseman J.
The great paper waste: the use of unsolicited medical literature by general practitioners
New Zealand Family Physician 1985;12:96-98
HSL3710
Collier J.
Ethics of drug marketing
Lancet 1985;1:166-167
HSL3711
Curran V, Golombok S.
Bottling it up
1985
HSL3724
Magor G.
Who sends junk mail?
Canadian Family Physician 1985;31:911
HSL3727
Mintz M.
At any cost: corporate greed, women, and the Dalkon Shield
1985
HSL3735
Woods D.
Annual report to the readers
Canadian Medical Association Journal 1985;132:7
HSL3736
Woods D, Radford T.
Annual meeting 1985
Canadian Medical Association Journal 1985;133:591-594, 597
HSL3625
Collier J.
Misleading advertisements: sanctions and corrections.
Lancet 1984 Nov 10;2(8411):1097-8
HSL3639
Lexchin J.
Pharmaceutical advertising in medical journals.
Can Med Assoc J 1984 Sep 15;131(6):544-6
HSL3618
Some dodgy claims for pirbuterol (Exirel)--a beta 2 agonist.
Drug Ther Bull. 1984 Sep 10;22(18):70-2
HSL3690
Joubert PH, Skene D.
Attitudes of private medical practitioners towards package inserts and other drug information sources.
S Afr Med J 1984 Aug 25;66(8):306-7
HSL3683
Collier JG, Pilkington TRE.
Human insulin: a misleading advertisement?
British Medical Journal 1984 Jul 21;289:191
HSL3684
Knight RK, Gennery BA.
Human insulin: a misleading advertisement? [reply]
British Medical Journal 1984 Jul 21;289:191
HSL3628
Collier J, New L.
Illegibility of drug advertisements.
Lancet 1984 Feb 11;1(8372):341-2
HSL3614
Advertiser wins CMAJ award
Canadian Medical Association Journal 1984;131:58
HSL3621
Berner MS.
‘Misleading’ drug ad
Canadian Family Physician 1984;30:271-272
HSL3622
Buckley EG.
Preventing promotion
Journal of the Royal College of General Practitioners 1984;37:473
HSL3633
Henderson IWD.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984;131:546
HSL3641
Lexchin J.
The real pushers: a critical analysis of the Canadian drug industry
1984
HSL3645
Morgan PP.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984;130:1412
HSL3662
Wright T.
Legibility of advertisements
Lancet 1984;2:1396
HSL3572
Barker C.
The Mozambique pharmaceutical policy.
Lancet 1983 Oct 1;2(8353):780-2
HSL3577
Connors JM.
More on junk mail
New England Journal of Medicine 1983;309:673-674
HSL3575
Breslow RA.
Junk mail
New England Journal of Medicine 1983;308:1168
HSL3583
Gray R, Smith M.
Is criticism of tranquilizer advertising justified?
Medical Marketing & Media 1983;18(7):50, 52, 54-55, 58-59
HSL3588
McAuley RG, Little F.
Junk mail
Canadian Medical Association Journal 1983;129:1174, 1176
HSL3594
Smith MC.
An analysis of the impact of print advertising on prescribing
1983:259-278
HSL3596
Wright L.
Pharmaceutical advertising
New Zealand Medical Journal 1983;96:407
HSL3532
The influence of drug advertisements.
Lancet. 1982 Dec 4;2(8310):1257-8
HSL3550
O'Malley K, O'Hanrahan M.
Drug promotion and the doctor.
Br J Clin Pharmacol 1982 Nov;14(5):661-4
HSL3537
Cohn JN.
Science and advertising.
Circulation 1982 May;65(5):839-40
HSL3556
Soffer A.
Free medical publications or scientific medical journals.
Chest 1982 Apr;81(4):397-8
HSL3535
Blum A.
The subject of advertising
Medical Journal of Australia 1982;2:61
HSL3538
Cooperstock R, Hill J.
The effects of tranquillization: benzodiazepine use in Canada
Health and Welfare Canada 1982
HSL3545
Medawar C.
Marketing and use of pharmaceuticals—bad information means bad medicine
1982
HSL3547
Melville A, Johnson C.
Cured to death: the effects of prescription drugs
1982
HSL3560
Victora CG.
Statistical malpractice in drug promotion: a case-study from Brazil.
Soc Sci Med 1982;16(6):707-9
HSL3529
Richter R.
Pesticides and pills: for export only Part two: pharmaceuticals
1981 Oct 24
HSL3495
Journal IN.
Lancet 1981;2:801
HSL3497
Blum R, Kreitman K.
Factors affecting individual use of medicines
1981:122-185
HSL3515
Leffler KB.
Persuasion or information? The economics of prescription drug advertising
Journal of Law and Economics 1981;24:45-74
HSL3516
Mark JA, Honigman B.
The weight of evidence
New England Journal of Medicine 1981;305:175
HSL3517
Meadows R.
Communicating new drug information—the medium is the message
Drug Information Journal 1981;15:11-15
HSL3520
Schneiweiss F.
Pharmaceutical advertising and the medical journal
Drug Information Journal 1981;15:193-197
HSL3481
Strickland-Hodge B, Jeqson MH.
Usage of information sources by general practitioners.
J R Soc Med 1980 Dec;73(12):857-62
HSL3492
Siskind V.
Prescription drug advertising
Medical Journal of Australia 1980 Jun 14;67:615, 617
HSL3475
King E.
Sex bias in psychoactive drug advertisements.
Psychiatry 1980 May;43(2):129-37
HSL3490
Joan SW.
Keeping prescription drug advertising honest: FDA's watchful eye
American Pharmacy 1980 May;20(5):40-44
HSL3491
Woody E Jr.
The paradox of pharmaceutical advertising.
J Med Assoc Ga 1980 May;69(5):379
HSL3489
Babich F, Moore J.
Prescription drug advertising
Medical Journal of Australia 1980 Mar 22;67:282
HSL3465
Goyan JE.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302(5):296
HSL3482
Thron CD.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302(5):295
HSL3484
Youman JD.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302(5):295
HSL3485
Young RS.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302(5):295-6
HSL2726
Walton H.
Ad Recognition and Prescribing by Physicians
Journal of Advertising Research 1980;20(3):39-48
Nil
HSL3460
Ethics and drug ads—a slip up in Bangladesh
1980;208:268-269
HSL3471
Hutchinson G.
Prescribing drugs—generic vs trade names
McGill Medical Journal 1980;46(1):2-6
HSL3474
Kellen A, Vandor T.
Commercial interruptions
Canadian Medical Association Journal 1980;123:12
HSL3477
Rheinstein P, Baum CS.
Labeling effectiveness and the health environment
1980;6:275-287
HSL3478
Rivin AU.
"Ethical" drugs.
Pharos Alpha Omega Alpha Honor Med Soc 1980 Spr;43(2):9-10
HSL3479
Stephenson PS, Walker GA.
Psychotropic drugs and women
Bioethics Quarterly 1980;2(1):20-38
HSL3483
Woods D.
And now, a word for our sponsor . . .
Canadian Medical Association Journal 1980;122:1343
HSL3459
Chapman S.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 29;66:700
HSL3458
Ferris JD.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 17;66:550
HSL3438
Relman AS.
Who reviews the ads?
N Engl J Med 1979 Nov 1;301(18):999
HSL3457
Tannock IF.
Responsibility in advertising: an oncologist's view
New England Journal of Medicine 1979 Nov 1;300:1004
HSL3419
Chapman S.
Advertising and psychotropic drugs: the place of myth in ideological reproduction.
Soc Sci Med [Med Psychol Med Sociol] 1979 Nov;13A(6):751-64
HSL3456
Kleinman G.
The physician’s drug adoption process re: product risk
Medical Marketing & Media 1979 Nov;14:46, 48-50
HSL3442
Solomon F, Mendelson WB.
Sleeping pills.
N Engl J Med 1979 Jul 26;301(4):214-5
HSL3448
Kelly NR.
Prescription drug advertising
Medical Journal of Australia 1979 Jul 14;66:40
HSL3444
Stock SL.
Junk mail.
N Engl J Med 1979 Jul 5;301(1):53
HSL3435
Najman JM, Siskind V, Bain C.
Prescription drug advertising: medical journal practices under different types of control.
Med J Aust 1979 May 19;1(10):420-4
HSL3445
Thompson EL.
Sexual bias in drug advertisements.
Soc Sci Med 1979 Mar;13A(2):187-91
HSL3429
Lion JR, Regan BL, Taylor RJ, Kutzer DJ.
Psychiatrists' opinions of psychotropic drug advertisements.
Soc Sci Med [Med Psychol Med Sociol] 1979 Jan;13A(1):123-5
HSL3425
Frisof KB, Parnicky K.
The burden of junk mail
New England Journal of Medicine 1979;300:865-866
HSL3427
Hughes R, Brewin R.
The tranquilizing of America: pill popping and the American way of life
1979
HSL3434
Miller JA, Waller R.
Health care advertising: consumer vs. physician attitudes
Journal of Advertising 1979;8(4):20-29
HSL3437
Pyeritz RE.
The burden of junk mail
New England Journal of Medicine 1979;301:866
HSL3390
Green B.
The politics of psychoactive drug use in old age.
Gerontologist 1978 Dec;18(6):525-30
HSL3395
Kalb CC.
Psychological motivations in physician prescribing habits.
Med Mark Media 1978 Oct;13(10):43-5,
HSL2691
Dajda R.
Drug advertising and prescribing.
J R Coll Gen Pract 1978 Sep;28(194):538-41
Link to source with long URL
HSL3408
Walton H.
A case for medical journal advertising
Medical Marketing & Media 1978 Aug;13:37-43
HSL3447
Paine TF.
Advertising (quantified)
JAMA1979 May 25;241(21):2264 1979 May 25;241(21):2264
HSL3407
Peretz SM.
Medical journal advertising as currently viewed by the pharmaceutical industry.
J R Soc Med 1978 Apr;71(4):282-4
HSL3389
Medical journals and advertising
N Z Med J. 1978 Feb 22;87(606):139
HSL3391
Harrell GD, Lindsay CM.
Pharmaceutical marketing
1978:69-90
HSL3392
Holmes JD.
Drug advertisements information
New Zealand Medical Journal 1978;87:226
HSL3393
Holst H.
Unsolicited advertising
Canadian Medical Association Journal 1978;118:24
HSL3397
Lall S, Bibile S.
The political economy of controlling transnationals: the pharmaceutical industry in Sri Lanka, 1972-1976.
Int J Health Serv 1978;8(2):299-328
HSL3398
Larson LN, Smith MC.
An analysis of the effects of “fair balance” in prescription drug advertising
Medical Marketing & Media 1978;13(6):26-27, 31
HSL3399
Martin RW.
Drug advertisements
New Zealand Medical Journal 1978;87:295
HSL3400
Phillips JS.
Drug advertisements
New Zealand Medical Journal 1978;87:102-103
HSL3402
Rice DI.
Misleading advertising of drug products
Canadian Family Physician 1978;24:101-102
HSL3363
Holmes JD.
Prescribing information in drug advertisements.
N Z Med J 1977 Nov 23;86(600):467-9
HSL3351
Da Sylva NP.
Drug information sources for the practicing physician.
Drug Inf J 1977 Oct-Dec;11(4):235-7
HSL3367
Marchand CR.
Physician attitudes toward sources of drug information.
Drug Inf J 1977 Oct-Dec;11(4):225-6
HSL3360
Holland AE.
Representatives and advertisements as sources of information.
Postgrad Med J 1977 Sep;53(623):559-61
HSL3388
Smith MC, Strecker P, Hair JF.
Sex appeals in prescription drug advertising
Medical Marketing & Media 1977 Sep;12(9):64, 66-70
HSL3353
Dyer AE.
Drug information--too much, too little, to whom?
Drug Inf J 1977 Jul-Sep;11(3):125-9
HSL3384
Moser RH.
Advertising and our journal.
Ann Intern Med 1977 Jul;87(1):114-5
HSL3383
Cocking C.
The abuse of prescription drugs
Weekend Magazine 1977 Jun 18:16-19
HSL3365
Larson LN, Smith MC, Sharpe TR, Hy R, Garner DD.
Government regulation and the believability of prescription drug advertising. An application of attribution theory and test of symbolic impact
Drug Intell Clin Pharm. 1977 Jun 01;11(6):338-43
HSL3382
Smith MC.
Where are the blacks in prescription drug advertising?
Medical Marketing & Media 1977 May;12(5):47-49
HSL3374
Smith MC, Griffin L.
Rationality of appeals used in the promotion of psychotropic drugs. A comparison of male and female models
Soc Sci Med. 1977 Apr 01;11(6-7):409-14
HSL3376
Stimson GV.
Do drug advertisements provide therapeutic information?
J Med Ethics 1977 Mar;3(1):7-13
HSL3381
Prescott LF.
Drug promotion.
Br Med J 1977 Feb 26;1(6060):574-5
HSL3373
Smith MC.
Appeals used in advertisements for psychotropic drugs: an exploratory study.
Am J Public Health 1977 Feb;67(2):171-3
HSL3345
Advertising reform
Journal of the Royal College of General Practitioners 1977;27:387-389
HSL3350
Coleman V.
Paper doctors: a critical assessment of medical research
Temple Smith 1977
HSL3355
Heaton PB.
Include bibliography on ads, says reader
Canadian Family Physician 1977;23:533, 535
HSL3372
Silverman M.
The epidemiology of drug promotion
International Journal of Health Services 1977;7:157-166
HSL3305
Hendeles L.
Need for "counter-detailing" antibiotics.
Am J Hosp Pharm 1976 Sep;33(9):918-24
HSL3325
Cope JD.
The charges against O-T-C medicine advertising--are they deserved?
J Am Pharm Assoc 1976 Sep;16(9):500-4
HSL3329
Hodes B.
Are magazine ads for O-T-C drugs based on fact?
J Am Pharm Assoc 1976 Sep;16(9):513-5
HSL3323
Anonymous .
Standards in pharmaceutical advertising
Medical Journal of Australia 1976 Jun 5;63(23):855-856
HSL3304
Hemminki E.
Factors influencing drug prescribing--inquiry into research strategy.
Drug Intell Clin Pharm 1976 Jun;10(6):321-9
HSL3322
Mburu FM, Smith MC, Wetherbee H.
Humor in prescription drug advertising
Medical Marketing & Media 1976 Jun;11(6):38-39, 42, 44-45
HSL3298
Cady J.
An estimate of the price effects of restrictions on drug price advertising
Economic Inquiry 1976;14:493-510
HSL3299
A critical look at the drug industry: how profits distort medicine
1976:31
HSL3303
Hargraves R.
Introduction
Journal of Drug Issues 1976;6:1-5
HSL3308
Lexchin J.
About those drug ads . . .
Canadian Family Physician 1976;22:109-110
HSL3309
McCaffery M.
About those drug ads . . .
Canadian Family Physician 1976;22:110
HSL3310
Morgan AH, Jeffers TA, Petrie JC, Walker W.
Drug advertising in medical journals
British Journal of Clinical Pharmacology 1976;3:1057-1060
HSL3311
Mosher EH.
Portrayal of women in drug advertising: a medical betrayal
Journal of Drug Issues 1976;6:72-78
HSL3312
Nelson G.
Advertising and the national health
Journal of Drug Issues 1976;6:28-33
HSL3315
Schwartzman D.
Promotional expenditures
The Johns Hopkins University Press 1976:182-211
HSL3316
Silverman M, Lee PR.
Pills, profits & politics
University of California Press 1976
HSL3317
Singer R.
Ads and readers
Canadian Family Physician 1976;22:635
HSL3318
Smith MC.
Portrayal of the elderly in prescription drug advertising
The Gerontologist 1976;16:329-334
HSL3319
Spiller GW.
Ads and readers
Canadian Family Physician 1976;22:635
HSL3320
Stimson GV.
The extent of advertising of pharmaceutical products.
J R Coll Gen Pract 1976;26
HSL3321
Stimson GV.
The use of references in drug advertisements.
J R Coll Gen Pract 1976;26
HSL3331
Brooke P.
Promotional parameters: a preliminary examination of promotional expenditures
Journal of Drug Issues 1976;6(1):21-27
HSL3335
Halberstam M.
The other side of the coin: another physician views drug advertising
Journal of Drug Issues 1976;6(1):9-12
HSL3337
Kuriansky JB.
TV advertising and abuse of over-the-counter drugs
Journal of Drug Issues 1976;6(1):79-84
HSL3342
Ruskin A.
Social and regulatory consequences of misleading medical information
Journal of Drug Issues 1976;6(1):50-55
HSL3343
Stetler CJ.
Advertising of prescription medicines.
Journal of Drug Issues 1976;6(1):34-42
HSL3344
Watson M.
A physician views drug advertising
Journal of Drug Issues 1976;6(1)
HSL3286
Stimson GV.
Information contained in drug advertisements.
BMJ. 1975 Nov 29;4(5995):508-9
HSL2420
Stimson GV.
The message of psychotropic drug ads.
J Commun 1975 Summer;25(3):153-60
HSL3275
Mailloud J.
The drug companies role in the supply of information
1975 May 30-31
HSL3278
Prather J, Fidell LS.
Sex differences in the content and style of medical advertisements.
Soc Sci Med 1975 Jan;9(1):23-6
HSL3270
Prescription drug ads now to be prescreened
Canadian Family Physician 1975;21(8):23
HSL3273
Huse KD.
Medical advertising—the other side of the coin
Patient Management 1975;4(6):36-37
HSL3276
Mant A, Darroch DB.
Media images and medical images
Social Science and Medicine 1975;9:613-618
HSL3277
McCaffery M.
The muzzle muddle
Canadian Family Physician 1975;21(11):7
HSL3282
Responsible advertising
Medical Journal of Australia 1975;62:90
HSL3254
Woods D.
Prescription drugs and the patient's health.
Can Med Assoc J 1974 Dec 7;111(11):1269
HSL3269
Dryden A.
PMAC setting up board to pre-clear ads
Maclean Hunter 1974 Nov 18;79:3
HSL3245
Mcree C, Corder BF, Haizlip T.
Psychiatrists' responses to sexual bias in pharmaceutical advertising.
Am J Psychiatry 1974 Nov;131(11):1273-5
HSL3247
Moser RH.
Editorial: The continuing search: FDA drug information survey.
JAMA 1974 Sep 2;229(10):1336-8
HSL3268
Editorial
Advertising standards and the National Medical Media Council.
Med J Aust. 1974 Aug 10;2(6):189-90
HSL3234
Denies ads mislead, manipulate
Drug Merchandising 1974;55(4):51
HSL3235
Findings and conclusions of the NCCC [National Council of Churches of Christ] project on drug advertising
Journal of Drug Issues 1974;4